Thomas Andrew Davis - 04 Apr 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC.

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Thomas Davis
Issuer symbol
N/A
Transactions as of
04 Apr 2022
Net transactions value
-$1,364
Form type
4
Filing time
05 Apr 2022, 08:17:04 UTC
Previous filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale $1,364 -1,091 -1.6% $1.25 68,330 04 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.